that is not what the publisher stated ....said studies were essentially flawed and had more interest is meeting targets instead of creating viable outcomes
Thursday 15th July - NEJM, page-51
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.025(1.95%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.32 | $1.30 | $241.1K | 184.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8375 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 3003 | 1 |
View Market Depth
| Last trade - 10.08am 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |